Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Ahram Biosystems

Ahram Biosystems?uq=3Oe4kK1Z
2001 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$4.41M LATEST DEAL AMOUNT
4 INVESTORS
Description

Operator of a biotechnology firm intended to develop and commercialize innovative portable high-speed PCR devices. The company's biotechnology products create new life science tools in order to lead the next-generation molecular diagnostic market.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Primary Office
  • 1203 Youngdong Technotower
  • 300-4 Sungsu-dong 2-ga
  • Seoul, 133-120
  • South Korea

+82 00-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ahram Biosystems’s full profile, request a free trial.

Ahram Biosystems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 10-Mar-2017 $4.41M 000 Completed Generating Revenue
1. Later Stage VC 20-Mar-2015 00.000 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Ahram Biosystems Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
KTB Network (Seoul) Venture Capital Minority 000 0000 000000 0
Mega Investment Corporate Venture Capital Minority 000 0000 000000 0
Timewise Investment Venture Capital Minority 000 0000 000000 0
SV Investment Venture Capital Minority 000 0000 000000 0

Ahram Biosystems Executive Team (2)

Name Title Board
Seat
Contact
Info
Hyun Hwang Chief Executive Officer & Chairman
Jane Kim Chief Scientific Officer

Ahram Biosystems Board Members (1)

Name Representing Role Since Contact
Info
Hyun Hwang Ahram Biosystems Chief Executive Officer & Chairman 000 0000